74 related articles for article (PubMed ID: 22644853)
21. Preparation and characterization of a new polymorphic form and a solvate of glibenclamide.
Hassan MA; Sheikh Salem M; Sallam E; al-Hindawi MK
Acta Pharm Hung; 1997; 67(2-3):81-8. PubMed ID: 9223758
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a novel polymorphic form of celecoxib.
Lu GW; Hawley M; Smith M; Geiger BM; Pfund W
J Pharm Sci; 2006 Feb; 95(2):305-17. PubMed ID: 16369929
[TBL] [Abstract][Full Text] [Related]
23. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 1. Nedocromil magnesium.
Zhu H; Khankari RK; Padden BE; Munson EJ; Gleason WB; Grant DJ
J Pharm Sci; 1996 Oct; 85(10):1026-34. PubMed ID: 8897266
[TBL] [Abstract][Full Text] [Related]
24. Physicochemical characterization of glybuzole polymorphs and their pharmaceutical properties.
Otsuka M; Ofusa T; Matsuda Y
Drug Dev Ind Pharm; 1999 Feb; 25(2):197-203. PubMed ID: 10065353
[TBL] [Abstract][Full Text] [Related]
25. [Thermostability and crystal structure of anticancer drug dasatinib].
Zhao YN; Chen XQ; Zhu K; Li G
Yao Xue Xue Bao; 2011 Sep; 46(9):1104-7. PubMed ID: 22121783
[TBL] [Abstract][Full Text] [Related]
26. Characterization of solid-state forms of mebendazole.
Kumar S; Chawla G; Sobhia ME; Bansal AK
Pharmazie; 2008 Feb; 63(2):136-43. PubMed ID: 18380400
[TBL] [Abstract][Full Text] [Related]
27. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy.
Kanaujia P; Lau G; Ng WK; Widjaja E; Schreyer M; Hanefeld A; Fischbach M; Saal C; Maio M; Tan RB
Drug Dev Ind Pharm; 2011 Sep; 37(9):1026-35. PubMed ID: 21417604
[TBL] [Abstract][Full Text] [Related]
28. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
[TBL] [Abstract][Full Text] [Related]
29. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
[TBL] [Abstract][Full Text] [Related]
30. Solid-state characterization of tacrine hydrochloride.
Sorrenti M; Catenacci L; Bruni G; Luppi B; Bigucci F; Bettinetti G
J Pharm Biomed Anal; 2012 Apr; 63():53-61. PubMed ID: 22326286
[TBL] [Abstract][Full Text] [Related]
31. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
32. Polymorphism and pseudopolymorphism of acyclovir.
Sohn YT; Kim SH
Arch Pharm Res; 2008 Feb; 31(2):231-4. PubMed ID: 18365695
[TBL] [Abstract][Full Text] [Related]
33. Crystal form of cephradine.
Sohn YT; Park SH
Arch Pharm Res; 2006 Feb; 29(2):178-82. PubMed ID: 16526284
[TBL] [Abstract][Full Text] [Related]
34. [Preparation and characterization of solid dispersions of ginkgolides].
Ma L; Han L; Zhang Z; Wang J
Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1368-72. PubMed ID: 19771864
[TBL] [Abstract][Full Text] [Related]
35. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
[TBL] [Abstract][Full Text] [Related]
36. Crystal forms of ketorolac.
Sohn YT; Seo HO
Arch Pharm Res; 2004 Mar; 27(3):357-60. PubMed ID: 15089044
[TBL] [Abstract][Full Text] [Related]
37. Characterization and Stability of Amorphous Tadalafil and Four Crystalline Polymorphs.
Wei Y; Ling Y; Su M; Qin L; Zhang J; Gao Y; Qian S
Chem Pharm Bull (Tokyo); 2018; 66(12):1114-1121. PubMed ID: 30504628
[TBL] [Abstract][Full Text] [Related]
38. Generation and characterization of a new solid form of trehalose.
Pyszczynski SJ; Munson EJ
Mol Pharm; 2013 Sep; 10(9):3323-32. PubMed ID: 23863330
[TBL] [Abstract][Full Text] [Related]
39. Solution-mediated phase transformation of different roxithromycin solid-state forms: Implications on dissolution and solubility.
Aucamp M; Stieger N; Barnard N; Liebenberg W
Int J Pharm; 2013 Jun; 449(1-2):18-27. PubMed ID: 23578825
[TBL] [Abstract][Full Text] [Related]
40. [Polymorphism of shikimic acid].
Wang FF; Yang DZ; Lv Y
Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(15):2861-2863. PubMed ID: 28914029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
